[go: nahoru, domu]

ISTVAN BERCZI et al., 2005 - Google Patents

Host Defence: An Interaction of Neuroendocrine-, Metabolic-and Immune Mechanisms in the Interest of Survival

ISTVAN BERCZI et al., 2005

Document ID
6425479468550116669
Author
ISTVAN BERCZI L
CHOW D
Publication year
Publication venue
Natural Immunity

External Links

Snippet

The term natural resistance refers to the capacity of living organisms to withstand injury caused by physical, chemical and biological agents that may be present in the external or internal envi-ronment. This protection is mediated by the natural, or innate, immune system …
Continue reading at books.google.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application

Similar Documents

Publication Publication Date Title
Ferreira et al. Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue
Benca et al. Sleep and host defenses: a review
US20210244789A1 (en) Compositions and methods for treatment of intracellular damage and bacterial infection
Taub et al. Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways
JP2002511411A (en) Anti-inflammatory
Klein et al. Prenatal stress alters immune function in the offspring of rats
Yuan et al. Neutralization of IL-17 inhibits the production of anti-ANT autoantibodies in CVB3-induced acute viral myocarditis
Henneke et al. Perinatal development of innate immune topology
Santegoets et al. Toll-like receptors in rheumatic diseases: are we paying a high price for our defense against bugs?
US5605885A (en) Method for stimulating the immune system
US20230226145A1 (en) Mutant Peptides And Methods Of Treating Subjects Using The Same
Faist et al. Host defense dysfunction in trauma, shock and sepsis: mechanisms and therapeutic approaches
PT89573B (en) METHOD FOR THE REDUCTION OF IMMUNOGLOBULIN-MEDIATED RESPONSES
Faist et al. Immune consequences of trauma, shock, and sepsis: mechanisms and therapeutic approaches
Abramova et al. Cytokine levels in rat blood and brain structures after administration of lipopolysaccharide
CA2328529A1 (en) Immunoregulator from a human chorionic gonadotropin preparation
Fabisiak et al. Anti-inflammatory and antibacterial effects of human cathelicidin active fragment KR-12 in the mouse models of colitis: a novel potential therapy of inflammatory bowel diseases
Debets et al. Inhibitory effect of corticosteroids on the secretion of tumour necrosis factor (TNF) by monocytes is dependent on the stimulus inducing TNF synthesis.
Berczi et al. Host defence: an interaction of neuroendocrine-, metabolic-and immune mechanisms in the interest of survival
ISTVAN BERCZI et al. Host Defence: An Interaction of Neuroendocrine-, Metabolic-and Immune Mechanisms in the Interest of Survival
BR112019011832A2 (en) methods of treating ilc2 cell associated diseases
Saoudi et al. Prevention of experimental autoimmune uveoretinitis and experimental autoimmune pinealitis in (Lewis x Brown-Norway) F1 rats by HgCl2 injections.
Busch et al. Granulocyte colony-stimulating factor (G-CSF) reduces not only gram-negative but also gram-positive infection-associated proinflammatory cytokine release by interaction between Kupffer cells and leukocytes
RU2722161C1 (en) Method for prevention of gastrointestinal diseases of young cattle
WO2022247783A1 (en) Use of melanocortin receptor mc5r